Previous article
Routine Vitamin D Testing: Unnecessary and Ineffective
Sep 2024
Next article
Intra-Articular Steroids for Adhesive Capsulitis
Point-of-Care Guides

PREVENT Equations for Assessing Cardiovascular Risk

Mark H. Ebell, MD, MS

American Family Physician. 2024;110(3):305-306.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

MARK H. EBELL, MD, MS, University of Georgia, Athens, Georgia.

Address correspondence to Mark H. Ebell, MD, MS, at ebell@uga.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Goff DC, Lloyd-Jones DM, Bennett G, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014; 129(25 suppl 2): S74–S75]. Circulation. 2014;129(25 suppl 2):S49-S73.
  2. 2.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published corrections appear in Hypertension. 2018; 71(6): e136–e139, and Hypertension. 2018; 72(3): e33]. Hypertension. 2018;71(6):1269-1324.
  3. 3.Davidson KW, Barry MJ, Mangione CM, et al.; US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(16):1577-1584.
  4. 4.Mangione CM, Barry MJ, Nicholson WK, et al.; US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(8):746-753.
  5. 5.Lloyd-Jones DM, Wilson PWF, Larson MG, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94(1):20-24.
  6. 6.Moriarty F, Ebell MH. A comparison of contemporary versus older studies of aspirin for primary prevention. Fam Pract. 2020;37(3):290-296.
  7. 7.Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382(9907):1762-1765.
  8. 8.Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight - reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383(9):874-882.
  9. 9.Khan SS, Matsushita K, Sang Y, et al.; Chronic Kidney Disease Prognosis Consortium; American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association’s PREVENT equations [published correction appears in Circulation. 2024; 149(11): e956]. Circulation. 2024;149(6):430-449.

This guide is one in a series that offers evidence-based tools to assist family physicians in improving their decision-making at the point of care.

This series is coordinated by Mark H. Ebell, MD, MS, deputy editor for evidence-based medicine.

A collection of Point-of-Care Guides published in AFP is available at https://www.aafp.org/afp/poc.

Previous article
Routine Vitamin D Testing: Unnecessary and Ineffective
Sep 2024
Next article
Intra-Articular Steroids for Adhesive Capsulitis

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.